TRVI SG&A Expense Growth
Trevi Therapeutics Inc · SG&A Expense Growth
TRVI SG&A Expense Growth
Latest reported30.48%period ending
TRVI FY SG&A Growth (YoY) (0.00% → 30.48%)
Latest values, visible window
High-resolution chart · PNG
TRVI sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 30.4849% | |
| 18.623% | |
| 1.6579% | |
| 6.1209% | |
| -6.584% | |
| 39.0775% | |
| 68.4963% | |
| 102.4276% | |
| 25.4098% | |
| 0% |